Terms: = Colorectal cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG AND Treatment
18 results:
1. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers.
Liu H; Sima X; Xiao B; Gulizeba H; Zhao S; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):486. PubMed ID: 38773508
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
3. Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal cancer and Radiation Enteritis.
Lv M; Ding R; Ma P; Feng Y; Zeng S; Zhang Y; Shen W; Guan W; Xiangyu E; Zeng H; Yu J
Curr Pharm Des; 2024; 30(9):683-701. PubMed ID: 38415445
[TBL] [Abstract] [Full Text] [Related]
4. pparg activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil.
Schöckel L; Woischke C; Surendran SA; Michl M; Schiergens T; Hölscher A; Glass F; Kreissl P; Klauschen F; Günther M; Ormanns S; Neumann J
BMC Cancer; 2024 Feb; 24(1):234. PubMed ID: 38378472
[TBL] [Abstract] [Full Text] [Related]
5. SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway.
Shang K; Ma N; Che J; Li H; Hu J; Sun H; Cao B
BMC Cancer; 2023 Apr; 23(1):335. PubMed ID: 37041476
[TBL] [Abstract] [Full Text] [Related]
6. Molecular mechanism study and tumor heterogeneity of Chinese angelica and Fructus aurantii in the treatment of colorectal cancer through computational and molecular dynamics.
Huang H; Ke C; Zhang D; Wu J; Zhang P
Funct Integr Genomics; 2023 Mar; 23(2):106. PubMed ID: 36977932
[TBL] [Abstract] [Full Text] [Related]
7. Simultaneous or staged resection for synchronous liver metastasis and primary rectal cancer: a propensity score matching analysis.
Karam E; Bucur P; Gil C; Sindayigaya R; Tabchouri N; Barbier L; Pabst-Giger U; Bourlier P; Lecomte T; Moussata D; Chapet S; Calais G; Ouaissi M; Salamé E
BMC Gastroenterol; 2022 Apr; 22(1):201. PubMed ID: 35448953
[TBL] [Abstract] [Full Text] [Related]
8. Bioinformatics and
Qin J; Guo C; Yang L; Liang X; Jiao A; Lai KP; Yang B
Bioengineered; 2021 Dec; 12(2):12461-12469. PubMed ID: 34931923
[TBL] [Abstract] [Full Text] [Related]
9. The expression and clinical significance of GPR39 in colon cancer.
Wu X; Dou Y; Xu H; Jiang Z
Ir J Med Sci; 2022 Aug; 191(4):1577-1585. PubMed ID: 34586565
[TBL] [Abstract] [Full Text] [Related]
10. Effect of cetuximab combined with chemotherapy in treating metastatic colorectal cancer and its prognostic analysis.
Wu J; Wang Z; Jin C; Ren H; Hu Y; Yang B; Hu Y
J BUON; 2021; 26(1):101-108. PubMed ID: 33721439
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-related transcription factor regulatory networks in human colorectal cancer.
Hao S; Huo S; Du Z; Yang Q; Ren M; Liu S; Liu T; Zhang G
Medicine (Baltimore); 2019 Apr; 98(15):e15158. PubMed ID: 30985693
[TBL] [Abstract] [Full Text] [Related]
12. Outcome of surgery for recurrent anal cancer: results from a tertiary referral centre.
Bignell M; Chave H; Branagan G
Colorectal Dis; 2018 Sep; 20(9):771-777. PubMed ID: 29573536
[TBL] [Abstract] [Full Text] [Related]
13. Distinct gene regulatory programs define the inhibitory effects of liver X receptors and pparg on cancer cell proliferation.
Savic D; Ramaker RC; Roberts BS; Dean EC; Burwell TC; Meadows SK; Cooper SJ; Garabedian MJ; Gertz J; Myers RM
Genome Med; 2016 Jul; 8(1):74. PubMed ID: 27401066
[TBL] [Abstract] [Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating pparg in colorectal cancer.
Moon CM; Kwon JH; Kim JS; Oh SH; Jin Lee K; Park JJ; Pil Hong S; Cheon JH; Kim TI; Kim WH
Int J Cancer; 2014 Feb; 134(3):519-29. PubMed ID: 23852449
[TBL] [Abstract] [Full Text] [Related]
15. Deficiency of caveolin-1 in Apc(min/+) mice promotes colorectal tumorigenesis.
Friedrich T; Richter B; Gaiser T; Weiss C; Janssen KP; Einwächter H; Schmid RM; Ebert MP; Burgermeister E
Carcinogenesis; 2013 Sep; 34(9):2109-18. PubMed ID: 23640045
[TBL] [Abstract] [Full Text] [Related]
16. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
Pancione M; Sabatino L; Fucci A; Carafa V; Nebbioso A; Forte N; Febbraro A; Parente D; Ambrosino C; Normanno N; Altucci L; Colantuoni V
PLoS One; 2010 Dec; 5(12):e14229. PubMed ID: 21151932
[TBL] [Abstract] [Full Text] [Related]
18. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
[TBL] [Abstract] [Full Text] [Related]
